OQS
DFTX

Occudo Quantitative Strategies’s Definium Therapeutics DFTX Stock Holding History

Occudo Quantitative Strategies’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,864
Closed -$92.1K – 1084
2022
Q4 		$92.1K Buy
+41,864
New +$116K 0.01% 853

Other funds holding DFTX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Occudo Quantitative Strategies's DFTX Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Definium Therapeutics (DFTX) in Q1 2023, closing a stake of 41,864 shares — an estimated $92.1K sold.

Occudo Quantitative Strategies first reported a position in DFTX in Q4 2022 and held it in 1 quarter. The position peaked at $92.1K in Q4 2022. 88 funds tracked by Wall St. Rank hold DFTX as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Definium Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 41,864 Definium Therapeutics shares in Q1 2023, an estimated $92.1K.
  • Occudo Quantitative Strategies first reported a position in Definium Therapeutics in Q4 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Definium Therapeutics position peaked at $92.1K in Q4 2022.
  • 88 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.